Korean J Med.
2026 Apr;101(2):77-83. 10.3904/kjm.2026.101.2.77.
Sarcopenia in Patients with End-Stage Kidney Disease on Dialysis
- Affiliations
-
- 1Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
- KMID: 2579657
- DOI: http://doi.org/10.3904/kjm.2026.101.2.77
Abstract
- Sarcopenia is characterized by progressive loss of skeletal muscle mass accompanied by a decline in muscle strength and/or physical performance. Sarcopenia may develop in patients with end-stage kidney disease due to multiple contributing factors, including uremia, malnutrition, reduced physical activity, chronic inflammation, and dialysis-related factors. In this population, sarcopenia is strongly associated with decreased quality of life and increased mortality, underscoring the need for early diagnosis and timely intervention. This review was written to provide a comprehensive overview of sarcopenia pathophysiology, diagnostic criteria, and prevalence, and describe therapeutic strategies for sarcopenia in patients undergoing dialysis.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Peritoneal dialysis in children and adolescents
- New dialysis treatment options for patients with end-stage chronic kidney disease
- Recent innovations in renal replacement technology and potential applications to transplantation and dialysis patients: a review of current methods
- Risk factors for peptic ulcer disease in patients with end-stage renal disease receiving dialysis
- Periodontal status of end-stage renal disease patients undergoing dialysis and referred for intraoral evaluation prior to kidney transplant surgery
